Core Laboratories NV (CLB) Scheduled to Post Quarterly Earnings on Thursday
Core Laboratories NV (NYSE:CLB) is set to issue its Q316 quarterly earnings data on Thursday, October 20th.
Shares of Core Laboratories NV (NYSE:CLB) opened at 111.99 on Wednesday. The firm has a market cap of $4.94 billion, a PE ratio of 59.41 and a beta of 1.45. Core Laboratories NV has a 1-year low of $84.50 and a 1-year high of $135.49. The firm’s 50-day moving average price is $110.34 and its 200 day moving average price is $117.55.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 22nd. Shareholders of record on Friday, October 21st will be issued a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a yield of 1.96%. The ex-dividend date is Wednesday, October 19th. Core Laboratories NV’s dividend payout ratio is presently 117.65%.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/19/core-laboratories-nv-clb-scheduled-to-post-quarterly-earnings-on-thursday.html
A number of equities research analysts have weighed in on CLB shares. Citigroup Inc. lowered their price objective on Core Laboratories NV from $116.00 to $110.00 and set a “neutral” rating on the stock in a report on Wednesday, September 28th. Zacks Investment Research raised Core Laboratories NV from a “hold” rating to a “buy” rating and set a $138.00 price target on the stock in a research note on Wednesday, July 20th. JPMorgan Chase & Co. reissued a “buy” rating on shares of Core Laboratories NV in a research note on Thursday, June 30th. Loop Capital began coverage on Core Laboratories NV in a research note on Friday, September 30th. They set a “hold” rating and a $120.00 price target on the stock. Finally, Credit Suisse Group AG began coverage on Core Laboratories NV in a research note on Thursday, September 1st. They set a “neutral” rating and a $115.00 price target on the stock. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $121.61.
Institutional investors have recently added to or reduced their stakes in the stock. Bessemer Group Inc. raised its position in Core Laboratories NV by 0.3% in the second quarter. Bessemer Group Inc. now owns 1,105,910 shares of the company’s stock worth $137,011,000 after buying an additional 3,784 shares during the period. BlackRock Institutional Trust Company N.A. raised its position in Core Laboratories NV by 10.2% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 798,509 shares of the company’s stock worth $98,927,000 after buying an additional 74,219 shares during the period. Massachusetts Financial Services Co. MA raised its position in Core Laboratories NV by 0.4% in the second quarter. Massachusetts Financial Services Co. MA now owns 755,716 shares of the company’s stock worth $93,625,000 after buying an additional 2,875 shares during the period. State Street Corp raised its position in Core Laboratories NV by 0.4% in the second quarter. State Street Corp now owns 466,446 shares of the company’s stock worth $57,790,000 after buying an additional 1,726 shares during the period. Finally, Van ECK Associates Corp raised its position in Core Laboratories NV by 0.5% in the second quarter. Van ECK Associates Corp now owns 344,478 shares of the company’s stock worth $42,677,000 after buying an additional 1,748 shares during the period.
About Core Laboratories NV
Core Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company’s services and products are directed toward enabling the Company’s clients to improve reservoir performance and increase oil and gas recovery from their producing fields.
Receive News & Ratings for Core Laboratories NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories NV and related companies with MarketBeat.com's FREE daily email newsletter.